98%
921
2 minutes
20
Background: In humans, blood circulating IgMIgDCD27 B cells are considered analogous to those described in the marginal zone of the spleen and are involved in important immunological processes. The homing receptors they express, and the organs involved in their development (for example, intestinal organs in rabbits) are only partially known. We recently reported that this population is heterogeneous and composed of at least two subsets: one expressing high levels of IgM - IgM B cells - and another low levels - IgM B cells.
Objectives: To evaluate the expression of homing receptors on IgDCD27 IgM and IgM B cells and quantify their frequencies in blood of control and appendectomized and/or tonsillectomized volunteers.
Materials And Methods: Using spectral flow cytometry, the simultaneous expression of 12 previously reported markers that differentiate IgM B cells and IgM B cells and of α4β7, CCR9, CD22 and CCR10 were evaluated in blood circulating B cells of control and appendectomized and/or tonsillectomized volunteers.
Results: The existence of phenotypically defined IgM and IgM B cell subsets was confirmed. They differentially expressed intestinal homing receptors, and the expression of α4β7 and CCR9 seems to determine new IgM subpopulations. IgM and IgM B cells were detected at lower frequencies in the appendectomized and/or tonsillectomized volunteers relative to controls.
Conclusions: Human blood circulating IgDCD27 IgM and IgM B cell subsets differentially express homing receptors, and it is necessary to investigate if mucosal organs are important in their development.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1080/08820139.2023.2187303 | DOI Listing |
Dermatol Ther (Heidelb)
September 2025
Department of Dermatology, Kyoto University, Kyoto, Japan.
Atopic dermatitis (AD) is a chronic inflammatory disease characterized by eczematous skin lesions, intense pruritus, skin pain, sleep disruption, and mental health disturbances. There remains a need for a therapeutic option that delivers durable efficacy, safety, and convenient dosing across the AD patient population. This review provides an overview of AD pathogenesis driven by T-cell imbalance and describes a novel therapeutic option targeting the OX40 receptor, a costimulatory molecule expressed specifically on activated T cells.
View Article and Find Full Text PDFInt J Nanomedicine
September 2025
State Key Laboratory of Cardiovascular Disease, National Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
Purpose: Acute myocardial infarction (AMI) is a major global health concern worldwide. The upregulation of the CD47 on apoptotic cardiomyocytes acts as a "don't-eat-me" signal, inhibiting the clearance of apoptotic cells by macrophages (a process known as efferocytosis) via the Signal Regulatory Protein α (SIRPα)/ SH2 Domain-Containing Phosphatase 1 (SHP1) axis, leading to secondary inflammatory activation. Additionally, impairment of this process can result in insufficient macrophage polarization towards the reparative M2 phenotype.
View Article and Find Full Text PDFStem Cell Res Ther
September 2025
Department of Plastic and Cosmetic Surgery, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Haikou, Hainan, 570311, China.
The interaction between interleukin-17 A (IL-17 A) and mesenchymal stromal cells (MSCs), and its role in immune regulation, is a new research field with broad application potential. This review aims to elucidate the complex relationship between IL-17 A and MSCs in immune regulation, and to provide a theoretical foundation and new insights for the development of immunotherapy strategies based on MSCs in the future. The review begins by summarizing the basic characteristics of IL-17 A and the immunomodulatory function of MSCs, and then delves into the regulation of IL-17 A by MSCs and the impact of IL-17 A on the immunomodulatory effects of MSCs and its potential mechanisms.
View Article and Find Full Text PDFFEBS Open Bio
August 2025
Departamento de Immunología, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Mexico.
Our group has previously reported that inhibin and its molecular pair, TGF-β type III receptor (TβRIII), regulate T cell development within the thymus. In addition, inhibins play a key role in immune tolerance through the modulation of dendritic cell (DC) maturation and peripheral Treg induction. However, the functional role of inhibins in T cell activation and differentiation is currently unknown.
View Article and Find Full Text PDFPharmaceuticals (Basel)
August 2025
Advanced Diagnostics and Therapeutics Institute, Health Sector, King Abdulaziz City for Science and Technology (KACST), Riyadh 11442, Saudi Arabia.
Conventional immunotherapy, including immune checkpoint blockade and chimeric antigen receptor (CAR)-T cells, has revolutionized cancer therapy over the past decade. Yet, the efficacy of these therapies is limited by tumor resistance, antigen escape mechanisms, poor persistence, and T-cell exhaustion, particularly in the treatment of solid tumors. The emergence of unconventional immunotherapies offers novel opportunities by leveraging diverse immune cell subsets and synthetic biologics.
View Article and Find Full Text PDF